Skip to main content

Find Clinical Trials

Home
Conditions
Cell Cycle Deregulation

Clinical trial condition

Cell Cycle Deregulation

Explore clinical trials studying Cell Cycle Deregulation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Cell Cycle Deregulation trial results

Recruiting

Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial

NCT06363734

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Department of Thoracic Medical Oncology, Tianjin Medical University Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details